ID   T2D1 HKSV#A
AC   CVCL_B5RJ
SY   T2D1 SV#A
DR   Wikidata; Q112041762
RX   PubMed=23197849;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): PubMed=23197849
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D18S51: 14,18
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 7,10
ST   D8S1179: 10,16
ST   FGA: 18,21
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
RX   PubMed=23197849; DOI=10.5966/sctm.2011-0044; PMCID=PMC3652675;
RA   Kudva Y.C., Ohmine S., Greder L.V., Dutton J.R., Armstrong A.S.,
RA   De Lamo J.G., Khan Y.K., Thatava T., Hasegawa M., Fusaki N.,
RA   Slack J.M.W., Ikeda Y.;
RT   "Transgene-free disease-specific induced pluripotent stem cells from
RT   patients with type 1 and type 2 diabetes.";
RL   Stem Cells Transl. Med. 1:451-461(2012).
//